Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.3%

3 terminated/withdrawn out of 223 trials

Success Rate

87.0%

+0.4% vs industry average

Late-Stage Pipeline

14%

32 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

61 recruiting

Enrollment Performance

Analytics

N/A
71(45.5%)
Phase 2
40(25.6%)
Phase 3
16(10.3%)
Phase 4
16(10.3%)
Early Phase 1
7(4.5%)
Phase 1
6(3.8%)
156Total
N/A(71)
Phase 2(40)
Phase 3(16)
Phase 4(16)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (223)

Showing 20 of 223 trials
NCT06561308Phase 2Recruiting

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Role: collaborator

NCT07272499Phase 2Recruiting

Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease

Role: collaborator

NCT07707232Recruiting

Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports

Role: lead

NCT05824923Phase 3Active Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Role: collaborator

NCT07707687Phase 2Recruiting

Safety and Efficacy of Eculizumab in High-risk TA-TMA

Role: collaborator

NCT07672210Recruiting

PregnAncy-Related Aortic DISsEction in China

Role: collaborator

NCT07692841Phase 3Recruiting

Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

Role: collaborator

NCT07690410Not Yet Recruiting

TMP-SMX for Non-HIV PCP: A Prospective Multicenter Study

Role: collaborator

NCT07665359Not ApplicableNot Yet Recruiting

Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD

Role: collaborator

NCT07661030Phase 4Not Yet Recruiting

The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution Time

Role: lead

NCT07209787Phase 4Recruiting

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Role: collaborator

NCT07632677Recruiting

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

Role: collaborator

NCT05356104Phase 2Recruiting

GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)

Role: collaborator

NCT05828953Phase 2Active Not Recruiting

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Role: lead

NCT07604688Recruiting

Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China

Role: collaborator

NCT06012760Not ApplicableRecruiting

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

Role: collaborator

NCT07613437Phase 2Not Yet Recruiting

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Role: collaborator

NCT06544083Recruiting

Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood

Role: collaborator

NCT07604896Phase 4Recruiting

Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs

Role: lead

NCT07604350Phase 3Not Yet Recruiting

Edaravone Dexborneol for Post-Stroke Epilepsy

Role: lead